Excipients: Magnesium carbonate, sucrose, corn starch, hydroxypropyl cellulose, methacrylic acid copolymer, talc, polyethylene glycol 6000, polysorbate 80, colloidal silica, purified water, titanium dioxide (E171).

Excipients in the capsule structure: Erythrosine (E127), titanium dioxide (E171), yellow iron oxide (E172), gelatin (bovine gelatin).

Read this leaflet carefully before you start using this medicine, because it contains important information for you.

Detailed information for this product is available in the patient information leaflet.

Instructions for proper use and dosage/frequency of administration

In the treatment of NSAID-associated duodenal and benign gastric ulcers in patients requiring continuous NSAID therapy.

For the prevention of NSAID-associated gastric and duodenal ulcers in at-risk patients (>65 years of age or history of gastric or duodenal ulcers) who require long-term NSAID therapy.

15 mg or 30 mg once daily for 4 weeks.

The starting dose is 60 mg once a day, although the dose is determined according to the patient’s needs, up to 180 mg can be administered per day.

Like all medicines, side effects may occur in people who are sensitive to the ingredients contained in LANSOR.

If any of the following occur, stop using LANSOR and IMMEDIATELY inform your doctor or go to the emergency department of the nearest hospital.

If you have one of these, it means you have a serious allergy to LANSOR. You may need emergency medical attention or hospitalization.

The following side effects may occur as a result of using LANSOR.

Common (may occur in less than 1 in 10 patients treated, but may occur in more than 1 in 100 patients)